At Dynamic Access, we specialize in midline IV insertions, providing patients with a safe and effective alternative for intravenous therapy. Our experienced vascular access specialists use advanced techniques and equipment to ensure each procedure is performed with precision and care. With 185,000+ vascular access procedures performed annually and coverage across 25 states, our board-certified VA-BC nurses bring proven expertise to every patient.
Our specialists use the latest techniques to ensure high success and minimal discomfort. 96%+ first-attempt success, overall >99%.
All procedures use state-of-the-art ultrasound guidance and sterile insertion techniques, provided at no capital cost to your facility.
Board-certified nurses are on-demand 24/7/365, often arriving in under 3 hours to deliver timely, safe care.
Clients get detailed logs and real-time dashboards. Supports 2,500+ facilities for oversight, benchmarking, and compliance.
Dynamic Access delivers expert Midline IV insertion and management with comfort and precision. Trusted by more than 2,500 facilities nationwide, our team can be operational within 90 days when requested by a hospital. Reach out to discuss how we can support your facility.
For Patients: A midline IV offers a more comfortable and durable option for intravenous therapy, reducing the need for frequent needle sticks and minimizing the risk of complications associated with short peripheral IVs.
For Healthcare Providers: Utilizing midline IVs can improve patient satisfaction, streamline workflows, and reduce the incidence of complications. These procedures also help hospitals reduce central line days and improve throughput, translating into measurable operational benefits.
A midline IV is a type of peripheral intravenous catheter inserted into a vein in the upper arm, typically the basilic, brachial, or cephalic veins. The catheter’s tip is positioned just below the shoulder, near the axillary region. Unlike traditional short peripheral IVs, midline IVs can remain in place for a longer duration — typically up to 1-4 weeks — making them ideal for patients requiring extended intravenous therapy. Evidence-based protocols reduce complications and support infection prevention across all care settings.
